Additionally, further cancer hallmarks analysis revealed a proliferation-related pathway, MYC targets v2 was significantly unregulated in C1, while C2, as a subtype with high stemness characteristics, was enriched for multiple oncogenic pathways, such as epithelial mesenchymal transition, angiogenesis, myogenesis, and apical junction (Figure 5C). Here, TRGV9 is linked to cancer.